Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

GRANISETRON HYDROCHLORIDE INJECTION 1 MG

GRANISETRON (GRANISETRON HYDROCHLORIDE) : 1 MG · DIN 02322765 · OMEGA LABORATORIES LIMITED

Health Canada status: MARKETED

What is GRANISETRON HYDROCHLORIDE INJECTION?

GRANISETRON HYDROCHLORIDE INJECTION 1 MG contains GRANISETRON (GRANISETRON HYDROCHLORIDE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02322765, held by OMEGA LABORATORIES LIMITED, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 14-May-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02322765
Brand nameGRANISETRON HYDROCHLORIDE INJECTION
Generic / active ingredientGRANISETRON (GRANISETRON HYDROCHLORIDE) : 1 MG
ManufacturerOMEGA LABORATORIES LIMITED
Strength1 MG
Dosage formLIQUID
Route of administrationINTRAVENOUS
SchedulePrescription
ATC codeA04AA02 GRANISETRON
AHFS class56:22.20
BiosimilarNo
Health Canada statusMARKETED
Status date14-May-2009
Original market date2009-05-14 00:00:00

Is GRANISETRON in shortage in Canada?

A Canadian shortage report is on file for this molecule: Resolved — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for GRANISETRON HYDROCHLORIDE INJECTION

What can be used instead?

Other Canadian products sharing ATC code A04AA02 GRANISETRON. 3 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
APO-GRANISETRON1 MGTABLETAPOTEX INCMARKETEDDIN 02308894
NAT-GRANISETRON1 MGTABLETNATCO PHARMA (CANADA) INCMARKETEDDIN 02452359
GRANISETRON HYDROCHLORIDE INJECTION1 MGLIQUIDSANDOZ CANADA INCORPORATEDCANCELLED POST MARKETDIN 02304708
GRANISETRON HYDROCHLORIDE INJECTION1 MGSOLUTIONSTRIDES PHARMA CANADA INCAPPROVEDDIN 02384108
GRANISETRON HYDROCHLORIDE INJECTION SDZ1 MGSOLUTIONSANDOZ CANADA INCORPORATEDCANCELLED POST MARKETDIN 02385414
GRANISETRON HYDROCHLORIDE INJECTION USP1 MGSOLUTIONHIKMA CANADA LIMITEDAPPROVEDDIN 02558408
JAMP GRANISETRON1 MGTABLETJAMP PHARMA CORPORATIONDORMANTDIN 02472686
KYTRIL 1MG/1ML1 MGLIQUIDHOFFMANN-LA ROCHE LIMITEDCANCELLED POST MARKETDIN 02088371
KYTRIL TABLETS 1MG1 MGTABLETHOFFMANN-LA ROCHE LIMITEDCANCELLED POST MARKETDIN 02185881

Who else supplies GRANISETRON worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. GRANISETRON appears in 56 registered pack listings across 11 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for GRANISETRON HYDROCHLORIDE INJECTION

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for GRANISETRON HYDROCHLORIDE INJECTION

Health Canada Drug Product Database (DPD), DIN 02322765. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.